Clinical Trial Update: Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe. [NA]

View source ↗

Summary

This clinical trial update describes the use of the 99mTc-3PRGD2 molecular imaging probe to image metastatic lymph nodes in gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 99mTc-3PRGD2 (3PRGD2 radiopharmaceutical)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Stomach Neoplasm, Lymph Node Metastasis | NA | Status: UNKNOWN